We are live on ! Find out more
PD

Point72 (DIFC) Portfolio holdings

AUM $1.53B
1-Year Est. Return 15.83%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+15.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.64B
AUM Growth
+$206M
Cap. Flow
-$30.6M
Cap. Flow %
-1.16%
Top 10 Hldgs %
20.71%
Holding
2,202
New
586
Increased
360
Reduced
541
Closed
708

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$21.9M
2
PM icon
Philip Morris
PM
+$20.8M
3
GE icon
GE Aerospace
GE
+$19.6M
4
CRH icon
CRH
CRH
+$19M
5
ABBV icon
AbbVie
ABBV
+$17.4M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$24.8M
2
CSCO icon
Cisco
CSCO
+$17.7M
3
QGEN icon
Qiagen
QGEN
+$14M
4
AVGO icon
Broadcom
AVGO
+$14M
5
SNOW icon
Snowflake
SNOW
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 13.75%
2 Technology 10.49%
3 Financials 6.05%
4 Industrials 4.83%
5 Consumer Discretionary 3.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
1451
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$646 ﹤0.01%
1,194
-23,374
-95% -$13.9K
SLQT icon
1452
SelectQuote
SLQT
$132M
$637 ﹤0.01%
+268
New +$703
ZURA icon
1453
Zura Bio
ZURA
$516M
$631 ﹤0.01%
+601
New +$718
OTLK icon
1454
Outlook Therapeutics
OTLK
$183M
$613 ﹤0.01%
+383
New +$611
MYO icon
1455
Myomo
MYO
$39M
$576 ﹤0.01%
267
+227
+568% +$823
NAUT icon
1456
Nautilus Biotechnolgy
NAUT
$124M
$572 ﹤0.01%
+789
New +$593
OBT icon
1457
Orange County Bancorp
OBT
$513M
$568 ﹤0.01%
+22
New +$537
SERA icon
1458
Sera Prognostics
SERA
$79.9M
$566 ﹤0.01%
+204
New +$505
TEAD
1459
Teads Holding Co
TEAD
$68.7M
$563 ﹤0.01%
227
-482
-68% -$1.46K
LNZA icon
1460
LanzaTech
LNZA
$61.2M
$523 ﹤0.01%
+19
New +$466
CLYM
1461
Climb Bio
CLYM
$681M
$522 ﹤0.01%
+421
New +$524
UEIC icon
1462
Universal Electronics
UEIC
$57.8M
$503 ﹤0.01%
76
– –
YSG
1463
Yatsen Holding
YSG
$322M
$501 ﹤0.01%
+52
New +$298
ADVM
1464
DELISTED
Adverum Biotechnologies
ADVM
$484 ﹤0.01%
+225
New +$629
GBIO
1465
DELISTED
Generation Bio
GBIO
$463 ﹤0.01%
+145
New +$559
TNYA icon
1466
Tenaya Therapeutics
TNYA
$161M
$462 ﹤0.01%
756
-10,272
-93% -$5.23K
CLBT icon
1467
Cellebrite
CLBT
$3.68B
$461 ﹤0.01%
+29
New +$517
NTNX icon
1468
Nutanix
NTNX
$16B
$459 ﹤0.01%
6
-9,841
-100% -$708K
HOWL icon
1469
Werewolf Therapeutics
HOWL
$17.2M
$439 ﹤0.01%
+403
New +$415
IGMS
1470
DELISTED
IGM Biosciences
IGMS
$435 ﹤0.01%
388
-456
-54% -$557
OVID icon
1471
Ovid Therapeutics
OVID
$414M
$429 ﹤0.01%
+1,301
New +$392
GALT icon
1472
Galectin Therapeutics
GALT
$196M
$395 ﹤0.01%
+187
New +$280
CDLX icon
1473
Cardlytics
CDLX
$21.7M
$374 ﹤0.01%
23
-258
-92% -$4.46K
PRPL icon
1474
Purple Innovation
PRPL
$35.3M
$362 ﹤0.01%
+20
New +$368
TPIC
1475
DELISTED
TPI Composites
TPIC
$356 ﹤0.01%
+414
New +$421
57 58
59
60 61

Similar funds

HT
HAP Trading New York $1.42B AUM 41.92% 1-Year Est. Return
SIMG
Sonora Investment Management Group Tucson, Arizona $1.41B AUM 20.58% 1-Year Est. Return
4CM
400 Capital Management New York $1.4B AUM
SAM
Scion Asset Management Saratoga, California $1.38B AUM 43.96% 1-Year Est. Return
CCB
Country Club Bank Kansas City, Missouri $1.69B AUM 16.93% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
P
Pitcairn Conshohocken, Pennsylvania $1.27B AUM 23.64% 1-Year Est. Return
FSC
Full Sail Capital Oklahoma City, Oklahoma $1.81B AUM 10.99% 1-Year Est. Return

Point72 (DIFC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Point72 (DIFC) held 2,202 positions worth $2.64B, up 8.4% from $2.44B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Point72 (DIFC)'s Q2 2025 filing shows 586 new, 360 increased, 541 reduced and 708 closed positions. Its largest new stake was Thermo Fisher Scientific: 52,494 shares worth $21.3M. The largest sale was Meta Platforms (Facebook), an estimated $24.8M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

  • Point72 (DIFC)'s largest Q2 2025 buy was Thermo Fisher Scientific: 52,494 shares worth $21.3M.
  • Point72 (DIFC) added most to CRH in Q2 2025, an estimated $19M increase.
  • Point72 (DIFC)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $24.8M.
  • Point72 (DIFC) fully exited Cisco in Q2 2025, selling an estimated $17.7M.
  • Point72 (DIFC)'s ten largest holdings make up 21% of its $2.64B portfolio in Q2 2025.
  • Point72 (DIFC) opened 586 new positions and closed 708 in Q2 2025.
  • Point72 (DIFC)'s portfolio value rose 8.4% quarter-over-quarter to $2.64B.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.